Trial intelligence / Profile preview

Peritoneal Transport With a New Bicarbonate-based Peritoneal Dialysis Solution Compared to Conventional Solution

NCT07621627Phase 3Completed

Sponsor
Karolinska Institutet
Start
Sep 1997
Primary completion
Nov 1997
Countries
1
01

Overview

Phase 3, randomised trial of Physioneal in chronic kidney disease (CKD) (2 arms), sponsored by Karolinska Institutet. Primary endpoint: Difference in net ultrafiltration at 4 hours. Started Sep 1997; status: completed.

02

Drugs

Physioneal
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on NCT07621627.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07621627.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call